10-deacetyltaxol has been researched along with docetaxel in 2 studies
| Studies (10-deacetyltaxol) | Trials (10-deacetyltaxol) | Recent Studies (post-2010) (10-deacetyltaxol) | Studies (docetaxel) | Trials (docetaxel) | Recent Studies (post-2010) (docetaxel) |
|---|---|---|---|---|---|
| 23 | 0 | 11 | 101 | 0 | 33 |
| Protein | Taxonomy | 10-deacetyltaxol (IC50) | docetaxel (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta chain | Homo sapiens (human) | 0.5 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.5 | |
| Substance-K receptor | Homo sapiens (human) | 1.563 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.5 | |
| Growth hormone-releasing hormone receptor | Homo sapiens (human) | 0.0001 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guénard, D; Guéritte-Voegelein, F; Lavelle, F; Le Goff, MT; Mangatal, L; Potier, P | 1 |
| Ballatore, C; Deiches, RF; Huryn, D; Hyde, E; Lee, VM; Smith, AB; Trojanowski, JQ | 1 |
2 other study(ies) available for 10-deacetyltaxol and docetaxel
| Article | Year |
|---|---|
Relationships between the structure of taxol analogues and their antimitotic activity.
Topics: Alkaloids; Animals; Antineoplastic Agents; Brain; Cell Division; Chemical Phenomena; Chemistry; Leukemia P388; Mice; Microtubules; Molecular Conformation; Molecular Structure; Paclitaxel; Stereoisomerism; Structure-Activity Relationship; Swine; Tubulin | 1991 |
Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies.
Topics: Animals; Blood-Brain Barrier; Brain; Carbamates; Chemistry, Pharmaceutical; Drug Design; Humans; Mice; Models, Chemical; Neurodegenerative Diseases; Paclitaxel; Permeability; Tauopathies; Time Factors | 2007 |